[1] Her research focuses on psychopharmacology and emotion, exploring novel treatments for depression and elucidating brain mechanisms underlying mood disorders.
Catherine Harmer attended Samuel Ward Academy in Haverhill, England, pursuing her higher education at the University of York, where she completed her undergraduate degree in psychology.
[2] Harmer leads the Psychopharmacology and Emotion Research Lab (PERL), a multidisciplinary team comprising psychiatrists, psychologists, neuroscientists, and pharmacologists.
Harmer has an H-index of 81, with 67 papers cited over 100 times, highlighting her significant impact on the field of cognitive neuroscience and psychopharmacology.
[3] Harmer served as the treasurer on the Executive Committee of the European College of Neuropsychopharmacology (ECNP) from 2019 to 2022,[4] and as president of British Association for Psychopharmacology (2024-2026).